Back

After initial improvement, left ventricular ejection fraction remains stable in long-term survivors with dilated cardiomyopathy

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores Ventricular Remodelling HFA Premium Access Heart Failure 2019

About the speaker

Photo
Ms Ane Knutsen

Akershus University Hospital, Nordbyhagen (Norway)

14 More presentations in this session

Presentation thumbnail
Multiple patterns of left ventricular diastolic function and its determinants in cardiac amyloidosis: an updated evaluation according to ASE/EACVI 2016 guidelines
Doctor S. Oghina (Creteil, FR)
Abstract Slides Video
Presentation thumbnail
High prevalence of cancer in patients with peripartum cardiomyopathy and potential pathophysiological connections
Doctor T. Pfeffer (Hannover, DE)
Abstract
Presentation thumbnail
Clinical utility of the IMPACT score for mortality prediction after heart transplantation: external validation study.
Doctor C. Ortiz-Bautista (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Genetic risk prediction of atrial fibrillation in a contemporary heart failure cohort
Miss M. Kloosterman (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Long-term left ventricular ejection fraction trajectory in diabetic patients: is there any difference?
Doctor M. De Antonio Ferrer (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Left ventricular reverse remodeling in heart failure with reduced ejection fraction: determinants and outcomes in a multidisciplinary heart failure clinic in a resource limited setting
thumbnail
Congress Presentation
New paradigms in pathological mechanosensing

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources